Abstract
Bone marrow transplants are an effective treatment for many life-threatening diseases. Considerations for use include potential for cure, availability of a suitable donor, feasibility of using autologous stem cells, and risks of transplant-related mortality. Not addressed in this article, but also important, is consideration of the relative efficacy of conventional therapy in specific settings. The IBMTR and ABMTR offer a unique resource for examining the role of allogeneic and autologous transplants in cancer treatment.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Actuarial Analysis
-
Blood Transfusion, Autologous / statistics & numerical data
-
Bone Marrow Transplantation / statistics & numerical data*
-
Global Health
-
Hematopoietic Stem Cell Transplantation / statistics & numerical data*
-
Humans
-
International Agencies / statistics & numerical data*
-
Leukemia / mortality
-
Leukemia / therapy
-
Lymphoma / mortality
-
Lymphoma / therapy
-
Neoplasms / mortality
-
Neoplasms / therapy
-
Registries / statistics & numerical data*
-
Retrospective Studies
-
Survival Analysis